Results for tag: "Flumequine"

The Flumequine market is a subset of the antibiotics market, focusing on the development and sale of flumequine-based drugs. Flumequine is a synthetic antibiotic used to treat a variety of bacterial infections, including those caused by Escherichia coli, Salmonella, and Shigella. It is also used to treat respiratory tract infections, urinary tract infections, and skin and soft tissue infections. Flumequine is generally well-tolerated and has a low risk of side effects. Flumequine is available in both oral and intravenous formulations, and is often used in combination with other antibiotics. It is also used in combination with other drugs to treat certain types of cancer. The Flumequine market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Sanofi, GlaxoSmithKline, and Novartis. Show Less Read more